2d
BioNTech Pivots Back to Oncology at JPM Conference, Teases 15 Phase III Readouts and $17B Cash Plan
BioNTech (NASDAQ:BNTX) used a presentation and question-and-answer session at the J.P. Morgan Healthcare Conference to ...
Mounting evidence from research on nematodes to mice indicate that a father's environment, such as what he eats or if he is ...
Team USA is already shaping up to be full of queer athletes, with three out women’s hockey players, Brittany Bowe and Conor ...
Key opportunities lie in next-generation sequencing methods, with hospitals as major end-users and North America as a ...
Asimov’s LV Edge Packaging cell line routinely achieves high titers for therapeutic transgenes and is now available at AGC Biologics’ Cell and Gene Center of ExcellenceBOSTON & MILAN--(BUSINESS WIRE)- ...
Scientists have discovered a new CRISPR mechanism with precise activity, expanding the potential applications of the existing ...
USU chemists’ CRISPR discovery could lead to single diagnostic test for viruses like COVID, flu, RSV
Researchers at Utah State University revealed new details about CRISPR immune system defenses, such as Cas12a3 systems, that ...
Researchers uncovered a previously unknown CRISPR immune response in bacteria that targets transfer RNAs. The newly ...
A novel CRISPR defense mechanism, unlike known nucleases, specifically destroys transfer ribonucleic acids (tRNA) that are ...
The new findings strengthen the "RNA world" hypothesis that describes how the first life on Earth could have used RNA instead ...
An international research team led by scientists from the University of Liège has discovered an interesting new therapeutic target for the treatment of melanoma resistant to targeted therapies.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback